Literature DB >> 15817768

Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs.

Shinya Fukumoto1, Yoh Tamaki, Hiroaki Shirafuji, Shinji Harakawa, Hiroshi Suzuki, Xuenan Xuan.   

Abstract

This is a report of a vaccine trial directed against Babesia gibsoni infection in dogs with the use of the recombinant antigen P50. Dogs immunized with P50 showed partial protection manifested as a significantly low level of parasitemia. The results indicated that P50 is a primary vaccine candidate molecule against canine B. gibsoni infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817768      PMCID: PMC1074387          DOI: 10.1128/CDLI.12.4.557-559.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  14 in total

Review 1.  Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

Authors:  J Schneider; S C Gilbert; C M Hannan; P Dégano; E Prieur; E G Sheu; M Plebanski; A V Hill
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

Review 2.  Designing blood-stage vaccines against Babesia bovis and B. bigemina.

Authors:  W C Brown; G H Palmer
Journal:  Parasitol Today       Date:  1999-07

Review 3.  Advances and prospects for subunit vaccines against protozoa of veterinary importance.

Authors:  M C Jenkins
Journal:  Vet Parasitol       Date:  2001-11-22       Impact factor: 2.738

4.  Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells.

Authors:  Shinya Fukumoto; Xuenan Xuan; Noriyuki Takabatake; Ikuo Igarashi; Chihiro Sugimoto; Kozo Fujisaki; Hideyuki Nagasawa; Takeshi Mikami; Hiroshi Suzuki
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Canine piroplasmosis due to Babesia gibsoni: clinical and morphological aspects.

Authors:  R Casapulla; L Baldi; V Avallone; R Sannino; L Pazzanese; V Mizzoni
Journal:  Vet Rec       Date:  1998-02-14       Impact factor: 2.695

6.  Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.

Authors:  H McShane; R Brookes; S C Gilbert; A V Hill
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.

Authors:  J Schneider; S C Gilbert; T J Blanchard; T Hanke; K J Robson; C M Hannan; M Becker; R Sinden; G L Smith; A V Hill
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

8.  Development of a preventive vaccine for Ebola virus infection in primates.

Authors:  N J Sullivan; A Sanchez; P E Rollin; Z Y Yang; G J Nabel
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

9.  Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris).

Authors:  E J Wozniak; B C Barr; J W Thomford; I Yamane; S P McDonough; P F Moore; D Naydan; T W Robinson; P A Conrad
Journal:  J Parasitol       Date:  1997-08       Impact factor: 1.276

10.  High-level expression of truncated surface antigen P50 of Babesia gibsoni in insect cells by baculovirus and evaluation of its immunogenicity and antigenicity.

Authors:  Shinya Fukumoto; Xuenan Xuan; Kimie Kadota; Ikuo Igarashi; Chihiro Sugimoto; Kozo Fujisaki; Hideyuki Nagasawa; Takeshi Mikami; Hiroshi Suzuki
Journal:  Clin Diagn Lab Immunol       Date:  2003-07
View more
  4 in total

1.  Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.

Authors:  Fujiko Sunaga; Sachiko Arai; Seigo Itoh; Satoshi Taharaguchi
Journal:  Parasitol Res       Date:  2014-02-18       Impact factor: 2.383

2.  Canine babesiosis: from molecular taxonomy to control.

Authors:  Peter J Irwin
Journal:  Parasit Vectors       Date:  2009-03-26       Impact factor: 3.876

Review 3.  New Molecules in Babesia gibsoni and their application for diagnosis, vaccine development, and drug discovery.

Authors:  Youn-Kyoung Goo; Xuenan Xuan
Journal:  Korean J Parasitol       Date:  2014-08-29       Impact factor: 1.341

Review 4.  The Etiology, Incidence, Pathogenesis, Diagnostics, and Treatment of Canine Babesiosis Caused by Babesia gibsoni Infection.

Authors:  Martina Karasová; Csilla Tóthová; Simona Grelová; Mária Fialkovičová
Journal:  Animals (Basel)       Date:  2022-03-16       Impact factor: 2.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.